Українська Русский English

ISSN 2522-9028 (Print)
ISSN 2522-9036 (Online)
DOI: https://doi.org/10.15407/fz

Fiziologichnyi Zhurnal

is a scientific journal issued by the

Bogomoletz Institute of Physiology
National Academy of Sciences of Ukraine

Editor-in-chief: V.F. Sagach

The journal was founded in 1955 as
1955 – 1977 "Fiziolohichnyi zhurnal" (ISSN 0015 – 3311)
1978 – 1993 "Fiziologicheskii zhurnal" (ISSN 0201 – 8489)
1994 – 2016 "Fiziolohichnyi zhurnal" (ISSN 0201 – 8489)
2017 – "Fiziolohichnyi zhurnal" (ISSN 2522-9028)

Fiziol. Zh. 2012; 58(3): 72-76


Kidneyfunction in oncologic patients after cisplastin chemotherapy

A.I. Gozhenko, A.M.Moskalenko, V.M. Sirman, A.A. Zhizhnevskaya, S.A. Storozhenko

    DP Ukrainian scientific Institute of Medicine of Transport,OdesaThe Center of transplantation of organs, tissues and cells,Ministry of Public Health of Ukraine, Kyiv.Odesa Region Oncological Center.


Abstract

During examination of kidney function under cisplastin chemotherapy in oncologic patients the nephrotoxicity of the drug have been shown during 24 hours after administration. We found that in 24 hours after injection of cisplastin in the dose 50 mg/m2 of the surface of the body, the excretion of creatinine, sodium, potassium, osmotic active compounds and chlorides is increased more than two times, indicating for disorder in osmolality, volume and ionic regulation of kidney function. The determined peculiarities are consequences of kidney injuries, which are confrmed by an increase in erythrocyte-and leucocyteuria. We showed that alterations in homeostatic kidney function is due to damage of renal tubules. Our study necessitates a need for renal protection during the whole period of cisplastin chemotherapy.

Keywords: cisplatin, nephrotoxicity, kidney function, renalprotection.

References

  1. Возіанов О.Ф., Гоженко А.І., Федорук О.С. Гостра ниркова недостатність. – Одеса: Вид-во Одеськ. мед. ун-ту, 2003. – 280 с.
  2. Гершанович М.Л. Осложнения при химио- и гормоно-терапии злокачественных опухолей. – М.: Медицина, 1982. – 153 с.
  3. Гоженко А.И. Энергетическое обеспечение основных почечных функций и процессов в норме и при по­вреждении почек: Автореф. дис. … д-ра мед. наук. – Черновцы, 1987. – 30 с.
  4. Гоженко А.И., Москаленко А.М., Стебловский В.В.. Жуков В.А. О нефротоксичности цисплатина у онкобольных // Актуал. пробл. транспорт. медицины. – 2010. – 19, № 1. – С. 81–86.
  5. Гоженко А.І., Пішак В.П., Роговий Ю.Є. Тубуло-інтерстиціальний синдром. – Чернівці: Медакадемія, 2002. – 221 с.
  6. Компендіум 2010 – лікарські препарати. Ред. В.М. Коваленка, О.П. Вікторова. – К.: Моріон, 2010. – 229 с.
  7. Переводчикова Н.И. Руководство по химиотерапии опухолевых заболеваний. – М.: Практ. медицина, 2005. – С. 155, 601–603.
  8. Cynthia A. Naughton. Drug-Induced Nephrotoxicity // Amer. Fam. Physician. – 2008. – 78(6). – P. 743–750.
  9. 9. Morgan K.P., Buie L.V., Savage S.W. The role of mannitol as a nephroprotectant in patients receiving cisplatin tgerapy // Ann Pharmacother. – 2012, 46(2). – Р. 276–281.
  10. 10. Perazella MA. Drug-induced nephropathy: an update // Exp. Opin Drug Saf. – 2005. – 4(4). – Р. 689–706.

© National Academy of Sciences of Ukraine, Bogomoletz Institute of Physiology, 2014-2019.